 | Do Directors Own Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Shares?
finance.yahoo.com - November 18 at 7:22 AM |
 | FY2019 Earnings Forecast for Allena Pharmaceuticals Inc (NASDAQ:ALNA) Issued By Jefferies Financial Group
www.americanbankingnews.com - November 18 at 2:48 AM |
| FY2019 Earnings Forecast for Allena Pharmaceuticals Inc (NASDAQ:ALNA) Issued By Wedbush
www.americanbankingnews.com - November 18 at 2:48 AM |
| Allena Pharmaceuticals Inc (NASDAQ:ALNA) Short Interest Update
www.americanbankingnews.com - November 16 at 4:24 AM |
| Zacks: Brokerages Anticipate Allena Pharmaceuticals Inc (NASDAQ:ALNA) Will Announce Earnings of -$0.46 Per Share
www.americanbankingnews.com - November 14 at 11:36 PM |
| Allena Pharmaceuticals' (ALNA) Buy Rating Reaffirmed at Cowen
www.americanbankingnews.com - November 14 at 8:49 PM |
| Allena Pharmaceuticals (NASDAQ:ALNA) Issues Earnings Results
www.americanbankingnews.com - November 14 at 4:36 PM |
| Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - November 13 at 12:06 PM |
 | Allena Demolished: Weak Phase III And Dismal Prognosis
seekingalpha.com - November 12 at 10:19 AM |
| Allena Pharmaceuticals (ALNA) Presents URIROX-1 and Study 206 Topline Results - Slideshow
seekingalpha.com - November 8 at 6:39 PM |
| Credit Suisse Group Downgrades Allena Pharmaceuticals (NASDAQ:ALNA) to Neutral
www.americanbankingnews.com - November 8 at 11:23 AM |
| Allena Pharma down 47% on "positive" reloxaliase data
seekingalpha.com - November 7 at 1:25 PM |
| Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results from URIROX-1 Trial and from Study 206
finance.yahoo.com - November 7 at 7:48 AM |
| Allena Pharmaceuticals Inc (NASDAQ:ALNA) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - November 1 at 11:03 PM |
| Allena Pharmaceuticals Inc (NASDAQ:ALNA) Short Interest Up 5.3% in October
www.americanbankingnews.com - November 1 at 1:19 AM |
| Assessing Allena Pharmaceuticals
seekingalpha.com - October 23 at 6:34 PM |
| Allena Pharmaceuticals to Present New Data on Reloxaliase and ALLN-346 Development Programs at Upcoming ASN Kidney Week and ACR/ARP Annual Meeting
finance.yahoo.com - October 17 at 8:28 AM |
| Allena Pharmaceuticals, Inc. (ALNA) Upgraded to Buy: Here's Why
finance.yahoo.com - October 8 at 12:45 PM |
 | ALNA Allena Pharmaceuticals, Inc. Common Stock
www.nasdaq.com - October 7 at 8:29 PM |
| Allena Pharma completes enrollment in late-stage study of reloxaliase in fat malabsorption disorder
seekingalpha.com - September 17 at 6:26 AM |
| Allena Pharmaceuticals Completes Enrollment in Pivotal Phase 3 URIROX-1 Trial Evaluating Reloxaliase in Patients with Enteric Hyperoxaluria
finance.yahoo.com - September 17 at 6:26 AM |
| Allena Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Enteric Hyperoxaluria and Potential for Reloxaliase
finance.yahoo.com - September 11 at 9:03 AM |
| Allena Pharmaceuticals: Unique Treatment For Enteric Hyperoxaluria Not Reflected In Valuation
seekingalpha.com - September 7 at 6:13 AM |
| Allena Pharmaceuticals to Participate in Upcoming Investor Conferences in September
finance.yahoo.com - August 29 at 11:13 AM |
| Allena Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - August 7 at 9:11 AM |
| Allena Pharmaceuticals to Present at 2019 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 6 at 8:36 AM |
| Can BD Medical Drive Becton, Dickinson's (BDX) Q3 Earnings?
finance.yahoo.com - July 31 at 6:56 PM |
| AmerisourceBergen (ABC) Q3 Earnings: What's in the Offing?
finance.yahoo.com - July 26 at 7:21 PM |
| Masimo (MASI) to Report Q2 Earnings: What's in the Offing?
finance.yahoo.com - July 26 at 10:31 AM |
| Will Flagship Impella Drive ABIOMED's (ABMD) Q1 Earnings?
finance.yahoo.com - July 26 at 10:31 AM |
| Allena: Kidney Contender With Dialysis In The News
seekingalpha.com - July 25 at 9:31 AM |
| Allena Pharma secures $10M capital raise
seekingalpha.com - June 28 at 9:22 AM |
| Allena Pharmaceuticals Showcases Reloxaliase and Enteric Hyperoxaluria Program at OHF International Hyperoxaluria Workshop
finance.yahoo.com - June 21 at 11:45 AM |
| Allena Pharmaceuticals Announces Interim Results from Study 206 of Reloxaliase in High Risk Patients with Advanced Oxalate Disorders
finance.yahoo.com - June 4 at 9:28 AM |
| Allena Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 30 at 9:24 AM |
| All You Need to Know About Allena Pharmaceuticals, Inc. (ALNA) Rating Upgrade to Buy
finance.yahoo.com - May 8 at 6:47 PM |
| Allena Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - May 8 at 9:20 AM |
| Investors Who Bought Allena Pharmaceuticals (NASDAQ:ALNA) Shares A Year Ago Are Now Down 52%
finance.yahoo.com - April 18 at 9:26 AM |
| Allena Pharmaceuticals Appoints Allene Diaz to its Board of Directors
finance.yahoo.com - April 17 at 9:37 AM |
| Allena Pharmaceuticals: Red Flags Abound, And That Makes This A Difficult Call
seekingalpha.com - April 6 at 9:19 AM |
| Allena Pharmaceuticals Announces Agreement with Duke Clinical Research Institute for URIROX-2 Pivotal Phase 3 Trial
finance.yahoo.com - March 27 at 9:43 AM |
 | Allena Pharmaceuticals Inc
www.bloomberg.com - March 18 at 6:45 PM |
| Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
finance.yahoo.com - March 7 at 9:51 AM |
| Allena Pharmaceuticals, Inc. to Present at 39th Annual Cowen & Co. Health Care Conference
finance.yahoo.com - March 5 at 9:48 AM |
| Allena Greatly Improves Phase III Design Endpoint Support, Improving Sentiment
seekingalpha.com - February 4 at 5:41 PM |
| Allena Pharmaceuticals appoints Louis Brenner as CEO
seekingalpha.com - January 4 at 10:17 AM |
| Allena Pharmaceuticals Announces Appointment of Louis Brenner, M.D. as Chief Executive Officer and Confirms Key Milestones for 2019
finance.yahoo.com - January 4 at 10:17 AM |
| Allena Pharmaceuticals aligns with FDA on phase 3 program and accelerated approval pathway for reloxaliase in enteric hyperoxaluria
seekingalpha.com - January 2 at 4:49 PM |
| Allena Pharmaceuticals Achieves Alignment with FDA on Phase 3 Program and Accelerated Approval Pathway for Reloxaliase in Enteric Hyperoxaluria
finance.yahoo.com - January 2 at 9:13 AM |
| Do Hedge Funds Love Allena Pharmaceuticals, Inc. (ALNA)?
finance.yahoo.com - December 24 at 9:07 AM |
